7A4H image
Entry Detail
PDB ID:
7A4H
EMDB ID:
Title:
Aquifex aeolicus lumazine synthase-derived nucleocapsid variant NC-2 (180-mer)
Biological Source:
PDB Version:
Deposition Date:
2020-08-19
Release Date:
2021-06-02
Method Details:
Experimental Method:
Resolution:
4.50 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Antitermination protein N,6,7-dimethyl-8-ribityllumazine synthase,6,7-dimethyl-8-ribityllumazine synthase
Chain IDs:A (auth: BA), B (auth: BB), C (auth: BC), D (auth: BD), E (auth: BE), F (auth: BF), G (auth: BG), H (auth: BH), I (auth: BI), J (auth: BJ), K (auth: BK), L (auth: BL), M (auth: BM), N (auth: BN), O (auth: BO), P (auth: AA), Q (auth: AB), R (auth: AC), S (auth: AD), T (auth: AE), U (auth: AF), V (auth: AG), W (auth: AH), X (auth: AI), Y (auth: AJ), Z (auth: AK), AA (auth: AL), BA (auth: AM), CA (auth: AN), DA (auth: AO), EA (auth: CA), FA (auth: CB), GA (auth: CC), HA (auth: CD), IA (auth: CE), JA (auth: CF), KA (auth: CG), LA (auth: CH), MA (auth: CI), NA (auth: CJ), OA (auth: CK), PA (auth: CL), QA (auth: CM), RA (auth: CN), SA (auth: CO), TA (auth: DA), UA (auth: DB), VA (auth: DC), WA (auth: DD), XA (auth: DE), YA (auth: DF), ZA (auth: DG), AB (auth: DH), BB (auth: DI), CB (auth: DJ), DB (auth: DK), EB (auth: DL), FB (auth: DM), GB (auth: DN), HB (auth: DO), IB (auth: EA), JB (auth: EB), KB (auth: EC), LB (auth: ED), MB (auth: EE), NB (auth: EF), OB (auth: EG), PB (auth: EH), QB (auth: EI), RB (auth: EJ), SB (auth: EK), TB (auth: EL), UB (auth: EM), VB (auth: EN), WB (auth: EO), XB (auth: FA), YB (auth: FB), ZB (auth: FC), AC (auth: FD), BC (auth: FE), CC (auth: FF), DC (auth: FG), EC (auth: FH), FC (auth: FI), GC (auth: FJ), HC (auth: FK), IC (auth: FL), JC (auth: FM), KC (auth: FN), LC (auth: FO), MC (auth: GA), NC (auth: GB), OC (auth: GC), PC (auth: GD), QC (auth: GE), RC (auth: GF), SC (auth: GG), TC (auth: GH), UC (auth: GI), VC (auth: GJ), WC (auth: GK), XC (auth: GL), YC (auth: GM), ZC (auth: GN), AD (auth: GO), BD (auth: HA), CD (auth: HB), DD (auth: HC), ED (auth: HD), FD (auth: HE), GD (auth: HF), HD (auth: HG), ID (auth: HH), JD (auth: HI), KD (auth: HJ), LD (auth: HK), MD (auth: HL), ND (auth: HM), OD (auth: HN), PD (auth: HO), QD (auth: IA), RD (auth: IB), SD (auth: IC), TD (auth: ID), UD (auth: IE), VD (auth: IF), WD (auth: IG), XD (auth: IH), YD (auth: II), ZD (auth: IJ), AE (auth: IK), BE (auth: IL), CE (auth: IM), DE (auth: IN), EE (auth: IO), FE (auth: JA), GE (auth: JB), HE (auth: JC), IE (auth: JD), JE, KE (auth: JF), LE (auth: JG), ME (auth: JH), NE (auth: JI), OE (auth: JJ), PE (auth: JK), QE (auth: JL), RE (auth: JM), SE (auth: JN), TE (auth: JO), UE (auth: KA), VE (auth: KB), WE (auth: KC), XE (auth: KD), YE (auth: KE), ZE (auth: KF), AF (auth: KG), BF (auth: KH), CF (auth: KI), DF (auth: KJ), EF (auth: KK), FF (auth: KL), GF (auth: KM), HF (auth: KN), IF (auth: KO), JF (auth: LA), KF (auth: LB), LF (auth: LC), MF (auth: LD), NF (auth: LE), OF (auth: LF), PF (auth: LG), QF (auth: LH), RF (auth: LI), SF (auth: LJ), TF (auth: LK), UF (auth: LL), VF (auth: LM), WF (auth: LN), XF (auth: LO)
Chain Length:197
Number of Molecules:180
Biological Source:Escherichia virus Lambda, Aquifex aeolicus VF5
Ligand Molecules
Primary Citation

Abstact

Viruses are ubiquitous pathogens of global impact. Prompted by the hypothesis that their earliest progenitors recruited host proteins for virion formation, we have used stringent laboratory evolution to convert a bacterial enzyme that lacks affinity for nucleic acids into an artificial nucleocapsid that efficiently packages and protects multiple copies of its own encoding messenger RNA. Revealing remarkable convergence on the molecular hallmarks of natural viruses, the accompanying changes reorganized the protein building blocks into an interlaced 240-subunit icosahedral capsid that is impermeable to nucleases, and emergence of a robust RNA stem-loop packaging cassette ensured high encapsidation yields and specificity. In addition to evincing a plausible evolutionary pathway for primordial viruses, these findings highlight practical strategies for developing nonviral carriers for diverse vaccine and delivery applications.

Legend

Protein

Chemical

Disease

Primary Citation of related structures